Latest News and Press Releases
Want to stay updated on the latest news?
-
4basebio PLC ("4basebio" or the "Company") Cambridge, UK, 31 March 2026 – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics,...
-
Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, including two rare kidney diseases, and SYFOVRE® FDA-approved...
-
Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, including two rare kidney diseases, and SYFOVRE® FDA-approved...
-
YieldMax ETFs Announces Weekly Distributions for Group 1 ETFs
-
Reykjavik, 31 March 2026: Reference is made to the stock exchange notice published by Kaldvik AS (the "Company") on 23 January 2026 with an update on the Company's financial situation. The Company...
-
Sunny Optical Reports FY2025 Earnings: The Stock Is Down, Revenue Is Up: What Is the Market Missing?
Sunny Optical Reports FY2025 Earnings: The Stock Is Down, Revenue Is Up: What Is the Market Missing?
-
RentRedi's 2026 survey reveals AI-powered accounting eliminates the #1 landlord tax prep bottleneck: expense categorization.
-
JERSEY CITY, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX) (“SCYNEXIS” or the “Company”), a biotechnology company focused on developing innovative new therapies to address...
-
Lubit CEO Kris Ewald Discusses Energy Price Prediction Market at EcoSummit
-
I fortsættelse af tidligere meddelelse d. 31 marts 2026 skal det herved oplyses, at det nu igen er muligt at stille indre værdier i nedenstående afdelinger, hvorfor Nykredit Portefølje Administration...